S&P 500: 666.06 -1.5% NASDAQ 100: 597.26 -1.7% Dow Jones: 467.48 -1.5%

Steven Cohen’s ORGO Holdings & Trades

First Buy
Q1 2023
Duration Held
5 Quarters
Largest Add
Q3 2023
+419,096 Shares
Current Position
389,246 Shares
$2.02 M Value

Steven Cohen's ORGO Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 389,246 shares of Organogenesis Holdings Inc. (ORGO) worth $2.02 M, representing 0.00% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 5 quarters.

Based on 13F filings, Steven Cohen has maintained this position in ORGO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2023, adding 419,096 shares. Largest reduction occurred in Q4 2023, reducing 425,000 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Organogenesis Holdings (ORGO) Holding Value Over Time

Track share changes against reported price movement

Quarterly Organogenesis Holdings (ORGO) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +389,246 New Buy 389,246 $5.18
Q4 2023 -425,000 Sold Out 0 $0.00
Q3 2023 +419,096 Add 7098.51% 425,000 $3.18
Q2 2023 -62,427 Reduce 91.36% 5,904 $3.32
Q1 2023 +68,331 New Buy 68,331 $2.13

Steven Cohen's Organogenesis Holdings Investment FAQs

Steven Cohen first purchased Organogenesis Holdings Inc. (ORGO) in Q1 2023, acquiring 68,331 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Organogenesis Holdings Inc. (ORGO) for 5 quarters since Q1 2023.

Steven Cohen's largest addition to Organogenesis Holdings Inc. (ORGO) was in Q3 2023, adding 425,000 shares worth $1.35 M.

According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 389,246 shares of Organogenesis Holdings Inc. (ORGO), valued at approximately $2.02 M.

As of the Q4 2025 filing, Organogenesis Holdings Inc. (ORGO) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Organogenesis Holdings Inc. (ORGO) was 425,000 shares, as reported at the end of Q3 2023.